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Patients With Congenitally
Corrected Transposition of the
Great Arteries and Systemic
Tricuspid Valve Regurgitation
Should Be Referred for
Surgical Consultation as
Soon as the Diagnosis of
Regurgitation Is Made*
Emile Bacha, MD
New York, New York
The title of this editorial comment was purposely chosen on
purpose to be as provocative as possible. The paper in this
issue of the Journal by Mongeon et al. (1) from the Mayo
Clinic comes from a group with premier credentials in adult
congenital heart disease. The Mayo Clinic has a real history
in adult congenital heart disease and surgery and has
methodically used its data to further our understanding of
the field. The present study is in many ways an update of
their previous publication from 1995 (2), focusing on the
relationship between systemic atrioventricular valve regur-
gitation (AVVR) in patients with congenitally corrected
transposition of the great arteries (CCTGA), timing of
surgery, and systemic ventricular ejection fraction (SVEF).
See page 2008
Since 1995, more data have accumulated, all confirming the
sobering findings of the natural history of CCTGA with
AVVR and the poor long-term surgical outcomes (3–5)
after systemic atrioventricular valve (tricuspid valve) replace-
ment or repair (6). This retrospective series is the largest
modern surgical series published to date and, despite some
flaws, is the best we have to better guide our patients.
*Editorials published in the Journal of the American College of Cardiology reflect the
views of the authors and do not necessarily represent the views of JACC or the
American College of Cardiology.
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Bacha has reported that he has no relationships to disclose.The findings are relatively straightforward: 1) Patients with
low pre-operative SVEF had the worst long-term surgical
outcomes; and 2) patients who underwent surgery before the
decline in SVEF (the authors chose a cutoff value of 40% on
the basis of their 1995 study) maintain a preserved ventricular
function. The latter finding in particular is not entirely intuitive
because it had not been clear that replacing a leaky tricuspid
valve in a CCTGA patient with preserved ventricular function
would halt the decline of ventricular function. It appears that it
does in most patients. Another pre-operative variable associ-
ated with late mortality was a subpulmonary ventricular systolic
pressure of50 mmHg. Interestingly also, the mean duration
f cardiopulmonary bypass was significantly (p 0.005) longer
n the patients whose SVEF decreased below 40% after surgery
ompared with patients who kept a post-operative SVEF
40%.Without wanting to expand more on this point (which
ould be a statistical fluke), it does seem to confirm my
ersonal bias that unlike most congenital heart surgery opera-
ions, where quality of the repair by far surpasses speed of the
peration in terms of impact on outcomes, replacement of a
ystemic atrioventricular valve in CCTGA is an operation that
as to be done expeditiously, with an eye on the clock.
Certainly the study has flaws: One wishes that SVEF had
een evaluated as a continuous variable, with repeated
easures over time. Systemic ventricular function could
ave been studied more comprehensively with magnetic
esonance. The follow-up could have been more complete
nd may have further strengthened the study findings, as
atients with SVEF 50% at surgery were under-
epresented in the survival analysis. The age range is 5 to 72
ears, and the study span is more than 4 decades. Realisti-
ally however, given the low incidence of this diagnosis, it is
nlikely that a much better study could be done, let alone a
rospective randomized study.
This study is important because it clarifies the issue of
arly operation in CCTGA and AVVR. Although no one
ad data to show previously, there has been speculation
efore on the analogy with early surgery for mitral regurgi-
ation and preservation of left ventricular ejection fraction
7). This analogy can only be limited, as the functional unit
f right ventricle and tricuspid valve (1 coronary, attachment
f the papillary muscle to the septum) are very different from
left ventricle and mitral valve (2 coronaries, no septal
ttachments), and, importantly, the mitral valve is typically
epaired, whereas the tricuspid valve in CCTGA is replaced
repairs have so far resulted in very high recurrence rates).
hat the authors have shown is that systemic ventricular
unction does not continue to deteriorate over time after
limination of AVVR. This alone is a very important
nding and should prompt earlier referrals to appropriately
hosen centers. In fact, this is even more compounded by
he fact that pre-operative SVEF is overestimated in the
resence of AVVR and decreases post-operatively after
limination of AVVR.
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May 17, 2011:2018–9 CCTGA and Systemic Tricuspid Valve RegurgitationOne of the key sentences in this paper is “. . .CCTGA
patients . . . are commonly referred late for surgical inter-
vention.” Indeed, most centers of expertise see such patients
too late. The only way forward in improving the natural
history of patients with CCTGA and AVVR, even mild
AVVR, is to consider early surgery. With improved short-
term surgical outcomes, even very early surgery in patients
with morphological abnormalities of the tricuspid valve
should be considered. This study gives us some objective
rationale for doing so.
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